Esophageal Cancer Clinical Trial

National Cancer Institute “Cancer Moonshot Biobank”

Summary

This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.

View Full Description

Full Description

PRIMARY OBJECTIVE:

I. To support current and future investigations into drug resistance and sensitivity and other National Cancer Institute (NCI)-sponsored cancer research initiatives through the procurement and distribution of multiple longitudinal biospecimens and associated data from a diverse group of cancer patients who are undergoing standard of care treatment at NCI Community Oncology Research Program (NCORP) sites.

SECONDARY OBJECTIVES:

I. To provide a service of value to study participants and their medical providers through the performance of molecular profiling assays on tumor samples in a Clinical Laboratory Improvement Act (CLIA)-certified laboratory and reporting of results to physicians and patients that they may opt to use in clinical management, including analysis of data for acquired resistance mechanisms.

II. To enable the development of patient-derived models such as cell lines and xenografts for cancer researchers through the provision of biospecimens from 20% of study participants to the NCI's Patient Derived Models Repository (PDMR), a national resource available to investigators.

III. To develop and implement robust approaches in patient and provider engagement to improve understanding of biobanking and its relationship to cancer research and increase representation of minority and underserved study participants in cancer research.

IV. To develop increased capabilities in United States (U.S.) community hospitals and clinics for contribution to cancer research through biobanking activities.

V. To enable secondary research generated from the project through deposition of data in public repositories such as Cancer Research Data Commons (CRDC), The Cancer Imaging Archive (TCIA) and database of Genotypes and Phenotypes (dbGAP), including clinical, radiology and pathology data with an emphasis on treatment response and outcome data.

VI. To provide residual biospecimens and associated data from the project to the cancer research community.

OUTLINE:

Patients undergo collection of tissue and blood samples prior to initiation of treatment, during treatment, and at disease progression. Patients with hematological malignancies also undergo collection of bone marrow and cerebral spinal fluid at the same time points. Archival blood and tissue, as well as bone marrow of patients with hematological malignancies, is also collected, if available. Patient medical records are reviewed, and data is collected for at least 10 years.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Is consistent with OR has been diagnosed with one of the following:

Colorectal cancer: Stage IV
Non-small cell or small cell lung cancer: stage III/IV
Prostate cancer: metastatic castration-resistant prostate cancer
Gastroesophageal cancer: stage IV
Melanoma: clinical stage IV with pathologic stage III OR clinical stage IV
Acute myeloid leukemia

Multiple myeloma

For the purposes of this study, re-staging is allowed

Patient should fit in one of the following four clinical scenarios (a-d)

Undergoing diagnostic workup for one of the diseases listed for which treatment will likely include a new regimen of standard of care therapy OR
Scheduled to begin treatment with a new regimen of standard of care therapy OR
Currently progressing on a regimen of standard of care therapy OR
Currently being treated with a regimen standard of care therapy, without evidence of progression

Requirements for fresh tissue biospecimen collections at enrollment:

For clinical scenarios a, b, and c above, freshly collected tumor tissue or bone marrow aspirate must be submitted at enrollment

For clinical scenarios a and b, the fresh tissue collection must be prior to starting therapy
For clinical scenario a, the biospecimen collection must be part of a standard of care medical procedure
For clinical scenarios b or c, the biospecimen collection may be part of a standard of care medical procedure OR

The biospecimen collection may be part of a study-specific procedure ("research only biopsy"), when the patient has a tumor amenable to image guided or direct vision biopsy and is willing and able to undergo a tumor biopsy for molecular profiling

Note: For research-only biopsies, the biopsy must not be associated with a significant risk of severe or major complications or death; the procedure cannot be a mediastinal, laparoscopic, open or endoscopic biopsy; nor can the procedure be a brain biopsy; nor can the patient be under the age of majority as determined by each U.S. state

Requirements for archival tissue:

For clinical scenarios a and b above, archival tissue as outlined below must be submitted IF AVAILABLE
For clinical scenarios c and d above, archival tissue as outlined below is REQUIRED

Pre-existing archival material (formalin-fixed, paraffin-embedded [FFPE] block, bone marrow aspirate, or unstained slides) that:

Contains the cancer type for which the participant is enrolled, and
Was collected no more than 5 years prior to initiation of therapy, and
Contains at least a surface area of 5 mm^2 and optimum surface area of 25 mm^2 or 3-5 mL cryopreserved bone marrow aspirate to yield 200 million bone marrow mononuclear cells, and
No more than 1 line of standard of care systemic therapy was administered from the date of archival material collection to the date of initiation of therapy
Requirements for blood collection: ALL scenarios require fresh blood collection at enrollment
Age 13 or older
Any sex and any gender
Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0, 1, or 2
Ability to understand and willingness to sign an informed consent document. Consent may be provided by a Legally Authorized Representative (LAR) in accordance with 45 CFR 46.102(i)

Exclusion Criteria:

Treated with or has already begun treatment with a non-standard of care therapeutic agent (investigational) in an interventional clinical trial
Uncontrolled intercurrent illness that in the physician's assessment would pose undue risk for biopsy
On chronic anticoagulation treatment that cannot be discontinued during the time interval necessary to undergo a biopsy
NCI PDMR EXCLUSION CRITERIA: Patients with CRC that is not mismatch repair deficient or microsatellite instability-high
NCI PDMR EXCLUSION CRITERIA: Patients with complete response
NCI PDMR EXCLUSION CRITERIA: Patients with invasive fungal infections

NCI PDMR EXCLUSION CRITERIA: Patients with active and/or uncontrolled infections or who are still recovering from an infection

Actively febrile patients with uncertain etiology of febrile episode
All antibiotics for non-prophylactic treatment of infection should be completed at least 1 week (7 days) prior to collection
No recurrence of fever or other symptoms related to infection for at least 1 week (7 days) following completion of antibiotics
NCI PDMR EXCLUSION CRITERIA: Patients with human immunodeficiency virus (HIV), active or chronic hepatitis (i.e. quantifiable hepatitis B virus [HBV]-deoxyribonucleic acid [DNA] and/or positive hepatitis B surface antigen [HbsAg], quantifiable hepatitis C virus [HCV]-ribonucleic acid [RNA]) or known history of HBV/HCV without documented resolution

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

1000

Study ID:

NCT04314401

Recruitment Status:

Recruiting

Sponsor:

National Cancer Institute (NCI)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 88 Locations for this study

See Locations Near You

Kingman Regional Medical Center
Kingman Arizona, 86401, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Mercy Hospital Fort Smith
Fort Smith Arkansas, 72903, United States More Info
Site Public Contact
Contact
800-378-9373
Jay W. Carlson
Principal Investigator
PCR Oncology
Arroyo Grande California, 93420, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Northside Hospital
Atlanta Georgia, 30342, United States More Info
Site Public Contact
Contact
404-303-3355
[email protected]
Stephen J. Wells
Principal Investigator
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah Georgia, 31405, United States More Info
Site Public Contact
Contact
912-819-5704
[email protected]
Grant C. Lewis
Principal Investigator
John H Stroger Jr Hospital of Cook County
Chicago Illinois, 60612, United States More Info
Site Public Contact
Contact
312-864-5204
Thomas E. Lad
Principal Investigator
Carle on Vermilion
Danville Illinois, 61832, United States More Info
Site Public Contact
Contact
800-446-5532
[email protected]
Kendrith M. Rowland
Principal Investigator
Cancer Care Specialists of Illinois - Decatur
Decatur Illinois, 62526, United States More Info
Site Public Contact
Contact
217-876-4762
[email protected]
Bryan A. Faller
Principal Investigator
Decatur Memorial Hospital
Decatur Illinois, 62526, United States More Info
Site Public Contact
Contact
217-876-4762
[email protected]
Bryan A. Faller
Principal Investigator
Carle Physician Group-Mattoon/Charleston
Mattoon Illinois, 61938, United States More Info
Site Public Contact
Contact
800-446-5532
[email protected]
Kendrith M. Rowland
Principal Investigator
Good Samaritan Regional Health Center
Mount Vernon Illinois, 62864, United States More Info
Site Public Contact
Contact
618-242-4600
Jay W. Carlson
Principal Investigator
Carle Cancer Center
Urbana Illinois, 61801, United States More Info
Site Public Contact
Contact
800-446-5532
[email protected]
Kendrith M. Rowland
Principal Investigator
McFarland Clinic PC - Ames
Ames Iowa, 50010, United States More Info
Site Public Contact
Contact
515-239-4734
[email protected]
Debra M. Prow
Principal Investigator
Physicians' Clinic of Iowa PC
Cedar Rapids Iowa, 52402, United States More Info
Site Public Contact
Contact
319-297-2900
William P. Fusselman
Principal Investigator
Oncology Associates at Mercy Medical Center
Cedar Rapids Iowa, 52403, United States More Info
Site Public Contact
Contact
319-363-2690
Deborah W. Wilbur
Principal Investigator
Blank Children's Hospital
Des Moines Iowa, 50309, United States
Iowa Methodist Medical Center
Des Moines Iowa, 50309, United States More Info
Site Public Contact
Contact
515-241-6727
Joshua Lukenbill
Principal Investigator
Medical Oncology and Hematology Associates-Des Moines
Des Moines Iowa, 50309, United States More Info
Site Public Contact
Contact
515-241-3305
Joshua Lukenbill
Principal Investigator
Our Lady of the Lake Physicians Group - Medical Oncology
Baton Rouge Louisiana, 70809, United States More Info
Site Public Contact
Contact
225-765-7659
[email protected]
Vince D. Cataldo
Principal Investigator
University Medical Center New Orleans
New Orleans Louisiana, 70112, United States More Info
Site Public Contact
Contact
504-210-3539
[email protected]
Augusto C. Ochoa
Principal Investigator
Children's Hospital New Orleans
New Orleans Louisiana, 70118, United States More Info
Site Public Contact
Contact
[email protected]
Augusto C. Ochoa
Principal Investigator
LSU Health Sciences Center at Shreveport
Shreveport Louisiana, 71103, United States More Info
Site Public Contact
Contact
318-813-1404
[email protected]
Gary V. Burton
Principal Investigator
Harold Alfond Center for Cancer Care
Augusta Maine, 04330, United States More Info
Site Public Contact
Contact
207-626-4855
Anne C. Breggia
Principal Investigator
Waldo County General Hospital
Belfast Maine, 04915, United States More Info
Site Public Contact
Contact
207-338-2500
Anne C. Breggia
Principal Investigator
MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford
Biddeford Maine, 04005, United States More Info
Site Public Contact
Contact
[email protected]
Anne C. Breggia
Principal Investigator
Franklin Memorial Hospital
Farmington Maine, 04938, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Stephens Memorial Hospital
Norway Maine, 04268, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Maine Medical Center-Bramhall Campus
Portland Maine, 04102, United States More Info
Site Public Contact
Contact
207-885-7565
Anne C. Breggia
Principal Investigator
Maine Medical Partners Surgical Care
Portland Maine, 04102, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
MMP Surgical Care Casco Bay
Portland Maine, 04102, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Penobscot Bay Medical Center
Rockport Maine, 04856, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford
Sanford Maine, 04073, United States More Info
Site Public Contact
Contact
[email protected]
Anne C. Breggia
Principal Investigator
Maine Children's Cancer Program
Scarborough Maine, 04074, United States More Info
Site Public Contact
Contact
207-396-7581
[email protected]
Anne C. Breggia
Principal Investigator
Maine Medical Partners Neurology
Scarborough Maine, 04074, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Maine Medical Partners - South Portland
South Portland Maine, 04106, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Maine Medical Partners Urology
South Portland Maine, 04106, United States More Info
Site Public Contact
Contact
207-396-8670
[email protected]
Anne C. Breggia
Principal Investigator
Saint Joseph Mercy Hospital
Ann Arbor Michigan, 48106, United States More Info
Site Public Contact
Contact
734-712-7251
[email protected]
Tareq Al Baghdadi
Principal Investigator
Saint Joseph Mercy Brighton
Brighton Michigan, 48114, United States More Info
Site Public Contact
Contact
734-712-7251
[email protected]
Tareq Al Baghdadi
Principal Investigator
Saint Joseph Mercy Canton
Canton Michigan, 48188, United States More Info
Site Public Contact
Contact
734-712-7251
[email protected]
Tareq Al Baghdadi
Principal Investigator
Saint Joseph Mercy Chelsea
Chelsea Michigan, 48118, United States More Info
Site Public Contact
Contact
734-712-7251
[email protected]
Tareq Al Baghdadi
Principal Investigator
Spectrum Health at Butterworth Campus
Grand Rapids Michigan, 49503, United States More Info
Site Public Contact
Contact
616-391-1230
[email protected]
Kathleen J. Yost
Principal Investigator
Saint Louis Cancer and Breast Institute-Ballwin
Ballwin Missouri, 63011, United States More Info
Site Public Contact
Contact
314-251-7058
Jay W. Carlson
Principal Investigator
Freeman Health System
Joplin Missouri, 64804, United States More Info
Site Public Contact
Contact
417-347-4030
[email protected]
Jay W. Carlson
Principal Investigator
Mercy Hospital Joplin
Joplin Missouri, 64804, United States More Info
Site Public Contact
Contact
417-556-3074
[email protected]
Jay W. Carlson
Principal Investigator
Delbert Day Cancer Institute at PCRMC
Rolla Missouri, 65401, United States More Info
Site Public Contact
Contact
573-458-7504
[email protected]
Jay W. Carlson
Principal Investigator
Mercy Clinic-Rolla-Cancer and Hematology
Rolla Missouri, 65401, United States More Info
Site Public Contact
Contact
573-458-6379
Jay W. Carlson
Principal Investigator
Heartland Regional Medical Center
Saint Joseph Missouri, 64506, United States More Info
Site Public Contact
Contact
816-271-7937
[email protected]
Jay W. Carlson
Principal Investigator
Saint Louis Cancer and Breast Institute-South City
Saint Louis Missouri, 63109, United States More Info
Site Public Contact
Contact
314-353-1870
Jay W. Carlson
Principal Investigator
Mercy Hospital South
Saint Louis Missouri, 63128, United States More Info
Site Public Contact
Contact
[email protected]
Jay W. Carlson
Principal Investigator
Missouri Baptist Medical Center
Saint Louis Missouri, 63131, United States More Info
Site Public Contact
Contact
314-996-5569
Bryan A. Faller
Principal Investigator
Mercy Hospital Saint Louis
Saint Louis Missouri, 63141, United States More Info
Site Public Contact
Contact
314-251-7066
Jay W. Carlson
Principal Investigator
Mercy Hospital Springfield
Springfield Missouri, 65804, United States More Info
Site Public Contact
Contact
417-269-4520
Jay W. Carlson
Principal Investigator
CoxHealth South Hospital
Springfield Missouri, 65807, United States More Info
Site Public Contact
Contact
417-269-4520
Jay W. Carlson
Principal Investigator
Mercy Hospital Washington
Washington Missouri, 63090, United States More Info
Site Public Contact
Contact
636-390-1600
Jay W. Carlson
Principal Investigator
CHI Health Saint Francis
Grand Island Nebraska, 68803, United States
Carson Tahoe Regional Medical Center
Carson City Nevada, 89703, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
OptumCare Cancer Care at Seven Hills
Henderson Nevada, 89052, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
OptumCare Cancer Care at Charleston
Las Vegas Nevada, 89102, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Hope Cancer Care of Nevada
Las Vegas Nevada, 89103, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Alliance for Childhood Diseases/Cure 4 the Kids Foundation
Las Vegas Nevada, 89135, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Comprehensive Cancer Centers of Nevada - Town Center
Las Vegas Nevada, 89144, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Comprehensive Cancer Centers of Nevada
Las Vegas Nevada, 89148, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
OptumCare Cancer Care at Fort Apache
Las Vegas Nevada, 89148, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Comprehensive Cancer Centers of Nevada - Central Valley
Las Vegas Nevada, 89169, United States More Info
Site Public Contact
Contact
702-384-0013
[email protected]
John A. Ellerton
Principal Investigator
Morristown Medical Center
Morristown New Jersey, 07960, United States More Info
Site Public Contact
Contact
973-971-5900
Eric D. Whitman
Principal Investigator
Newton Medical Center
Newton New Jersey, 07860, United States
Chilton Medical Center
Pompton New Jersey, 07444, United States More Info
Site Public Contact
Contact
973-971-5990
Eric D. Whitman
Principal Investigator
Overlook Hospital
Summit New Jersey, 07902, United States More Info
Site Public Contact
Contact
908-522-2043
Eric D. Whitman
Principal Investigator
Montefiore Medical Center-Einstein Campus
Bronx New York, 10461, United States More Info
Site Public Contact
Contact
718-379-6866
[email protected]
Balazs Halmos
Principal Investigator
Montefiore Medical Center-Weiler Hospital
Bronx New York, 10461, United States More Info
Site Public Contact
Contact
718-379-6866
[email protected]
Balazs Halmos
Principal Investigator
Children's Hospital at Montefiore
Bronx New York, 10467, United States More Info
Site Public Contact
Contact
718-379-6866
[email protected]
Balazs Halmos
Principal Investigator
Montefiore Medical Center - Moses Campus
Bronx New York, 10467, United States More Info
Site Public Contact
Contact
718-379-6866
[email protected]
Balazs Halmos
Principal Investigator
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York New York, 10032, United States More Info
Site Public Contact
Contact
212-305-6361
[email protected]
Benjamin Herzberg
Principal Investigator
Novant Health Presbyterian Medical Center
Charlotte North Carolina, 28204, United States
FirstHealth of the Carolinas-Moore Regional Hospital
Pinehurst North Carolina, 28374, United States More Info
Site Public Contact
Contact
910-715-3500
[email protected]
Charles S. Kuzma
Principal Investigator
Novant Health Forsyth Medical Center
Winston-Salem North Carolina, 27103, United States More Info
Site Public Contact
Contact
336-718-8335
[email protected]
Judith O. Hopkins
Principal Investigator
Mercy Hospital Oklahoma City
Oklahoma City Oklahoma, 73120, United States More Info
Site Public Contact
Contact
405-752-3402
Jay W. Carlson
Principal Investigator
Prisma Health Richland Hospital
Columbia South Carolina, 29203, United States More Info
Site Public Contact
Contact
864-241-6251
Ki Y. Chung
Principal Investigator
Prisma Health Baptist Hospital
Columbia South Carolina, 29220, United States More Info
Site Public Contact
Contact
864-241-6251
Ki Y. Chung
Principal Investigator
Gibbs Cancer Center-Gaffney
Gaffney South Carolina, 29341, United States More Info
Site Public Contact
Contact
864-560-6104
[email protected]
Michael Humeniuk
Principal Investigator
Prisma Health Greenville Memorial Hospital
Greenville South Carolina, 29605, United States More Info
Site Public Contact
Contact
864-241-6251
Ki Y. Chung
Principal Investigator
Gibbs Cancer Center-Pelham
Greer South Carolina, 29651, United States More Info
Site Public Contact
Contact
864-560-6104
[email protected]
Michael Humeniuk
Principal Investigator
Spartanburg Medical Center
Spartanburg South Carolina, 29303, United States More Info
Site Public Contact
Contact
864-560-6104
[email protected]
Michael Humeniuk
Principal Investigator
MGC Hematology Oncology-Union
Union South Carolina, 29379, United States More Info
Site Public Contact
Contact
864-560-6104
[email protected]
Michael Humeniuk
Principal Investigator
Centra Lynchburg Hematology-Oncology Clinic Inc
Lynchburg Virginia, 24501, United States More Info
Site Public Contact
Contact
434-200-5925
[email protected]
Andrew Poklepovic
Principal Investigator
VCU Massey Cancer Center at Stony Point
Richmond Virginia, 23235, United States More Info
Site Public Contact
Contact
[email protected]
Andrew Poklepovic
Principal Investigator
Virginia Commonwealth University/Massey Cancer Center
Richmond Virginia, 23298, United States More Info
Site Public Contact
Contact
[email protected]
Andrew Poklepovic
Principal Investigator
Valley Medical Center
Renton Washington, 98055, United States More Info
Site Public Contact
Contact
425-228-3440
[email protected]
John A. Ellerton
Principal Investigator
North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
Yakima Washington, 98902, United States More Info
Site Public Contact
Contact
509-574-3535
[email protected]
John A. Ellerton
Principal Investigator
Marshfield Medical Center-EC Cancer Center
Eau Claire Wisconsin, 54701, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Marshfield Medical Center-Marshfield
Marshfield Wisconsin, 54449, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Aurora Saint Luke's Medical Center
Milwaukee Wisconsin, 53215, United States More Info
Site Public Contact
Contact
414-302-2304
[email protected]
Rubina Qamar
Principal Investigator
Marshfield Clinic-Minocqua Center
Minocqua Wisconsin, 54548, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Marshfield Medical Center-Rice Lake
Rice Lake Wisconsin, 54868, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Marshfield Medical Center-River Region at Stevens Point
Stevens Point Wisconsin, 54482, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Marshfield Medical Center - Weston
Weston Wisconsin, 54476, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
Marshfield Clinic - Wisconsin Rapids Center
Wisconsin Rapids Wisconsin, 54494, United States More Info
Site Public Contact
Contact
800-782-8581
[email protected]
Adedayo A. Onitilo
Principal Investigator
San Juan Community Oncology Group
San Juan , 00917, Puerto Rico More Info
Site Public Contact
Contact
787-274-3387
Luis Baez-Diaz
Principal Investigator
Centro Comprensivo de Cancer de UPR
San Juan , 00927, Puerto Rico More Info
Site Public Contact
Contact
888-823-5923
[email protected]
Luis Baez-Diaz
Principal Investigator
San Juan City Hospital
San Juan , 00936, Puerto Rico More Info
Site Public Contact
Contact
787-763-1296
Luis Baez-Diaz
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Esophageal Cancer

Estimated Enrollment:

1000

Study ID:

NCT04314401

Recruitment Status:

Recruiting

Sponsor:


National Cancer Institute (NCI)

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.